Metabolic Disorders

Carmel, Indiana and Burlington, Massachusetts – August 27, 2026 MBX Biosciences announced that the first patient has been dosed...

INGELHEIM, Germany, July 16, 2026 Boehringer Ingelheim has initiated a Phase II clinical trial evaluating BI 3034701, an investigational...

SAN JOSE, Calif. | July 9, 2026 Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company pioneering oral biologic drug...

SAN DIEGO, June 24, 2026 Viking Therapeutics (NASDAQ: VKTX) announced the initiation of a Phase 1 clinical trial evaluating...

SAN FRANCISCO, May 6, 2026 Artera announced that the U.S. Food and Drug Administration (FDA) has granted clearance for...

SUZHOU, China, May 6, 2026 SiranBio announced a major global licensing agreement with GSK for its investigational siRNA therapeutic...

Basel, Switzerland – October 30, 2025 — Roche Holding AG (SIX: RO, ROG; OTCQX: RHHBY) has successfully completed its...